He is a cancer survivor - aided by scientists who test dozens of drugs on miniature tumours they grow using cells from children and teenagers with cancer. Each year, around 400,000 children and ...
Celltrion Inc., a major South Korean biopharmaceutical firm, said Friday its new biosimilar for an autoimmune disease treatment has received approval from the U.S. Food and Drug Administration (FDA).
Vertex has gained the FDA's approval for its non-addictive pain med Journavx, which becomes the first significant innovation in pain relief in more than two decades.